FDA Clearance Tracker · P020014-S038
CONCEPTUS ESSURE SYSTEM
Last checked: Nov 20, 2026Latest source record: Oct 2, 2012 (this decision)Source: openFDAMethods & limitations
Decided
Oct 2, 2012
Approved
Time to decision
169 days
Received Apr 16, 2012. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P020014-S038
- Device name
- CONCEPTUS ESSURE SYSTEM
- Applicant
- Bayer Pharma AG
- Applicant location
- Berlin
- Received
- Apr 16, 2012
- Decided
- Oct 2, 2012
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P020014
Device type
- Device class
- Class III
- Regulation
- 21 CFR 884.5380
- Specialty
- Obstetrics & Gynecology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR A MATERIAL CHANGE AND A MINOR PROCESS CHANGE. THE USE OF NEW CARBOTHANE MATERIALS IN THE DELIVERY CATHETER WITH THE NEW HYDROPHILIC COATING AND A CHANGE IN OPERATING TEMPERATURE.
Source documents
Other decisions for Bayer Pharma AG
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.